Pfizer Responds to the Coronavirus Pandemic

As the coronavirus disease (COVID-19) continues to spread, at Pfizer, we are committed to ensuring public health and safety for our colleagues, retirees, and global patient community. Learn more about COVID-19 and what you can do to stay safe and prevent the spread of this infectious disease. Please share these resources with your loved ones and friends.

COVID-19 Temporary Benefits Coverage Enhancements for U.S. Retirees

As the concerns and fears of the COVID-19 virus impact our daily lives, Pfizer has reviewed its U.S. medical plans to make it easier and less costly for retirees to receive the medical care, including testing for COVID-19, they may need.

Managing Your Mental Health During a Pandemic

The World Health Organization recently declared a pandemic in the wake of a global outbreak of the novel coronavirus disease (COVID-19).

All Hands on Deck as Scientists Revive SARS Protease Inhibitor to Attempt to Fight COVID-19

As scientists around the globe race to find ways to treat COVID-19, the fastest approach to finding a treatment may be to repurpose existing drugs in the hopes of avoiding having to start from “square one” on the drug development pathway.

4 Things to Know About the Science of Coronavirus

On Dec. 31 of last year, Chinese authorities alerted the World Health Organization to a mysterious virus causing pneumonia-like illness in a small cluster of patients in the city of Wuhan.

BioNTech and Pfizer Announce Regulatory Approval from German Authority Paul-Ehrlich-Institut to Commence First Clinical Trial of COVID-19 Vaccine Candidates

Pfizer Advances Battle Against COVID-19 on Multiple Fronts

Pfizer announced important advances in the battle against the global COVID-19 pandemic.

Join the Pfizer Plus Community Corner

When you join the community, you can get access to our special “member’s only” features including:

  • Member Only Content
  • Email Updates
  • Community